Laurie Huard, Karol Ford, Tania Obranovich, and John Alsobrook

Clinical Genomics has appointed Laurie Huard as chief operating officer, Karol Ford as vice president of sales and marketing, Tania Obranovich as vice president of intellectual property, legal affairs and compliance, and John Alsobrook as clinical laboratory director.

Huard comes to Clinical Genomics from Helomics where she served as vice president of operations. She has also served as a director for a large integrated hospital laboratory, and has operated a laboratory informatics consulting practice for more than 10 years. Ford comes to Clinical Genomics from Progenity, where she has held various positions. Obranovich currently practices law as a patent attorney. She has spent the last ten years as a partner at a top tier Australian intellectual property firm. Alsobrook comes to Clinical Genomics from DermTech where he served as chief science officer. He also served as CEO, director of discovery, and vice president of clinical laboratory operations at Exagen Diagnostics.